Intensive blood glucose lowering treatment proved fatal for diabetes patients


Intensive blood glucose lowering treatment proved fatal for diabetes patients

Intensive blood glucose lowering treatment proved fatal for diabetes patients in a US study, and for Safety, National Heart, Lung, and Blood Institute (NHLBI) has changed intensive blood sugar treatment strategy in clinical trial of diabetes and cardiovascular disease.

In this trial of adults with type 2 diabetes at especially high risk for heart attack and stroke, the medical strategy to intensively lower blood glucose (sugar) below current recommendations increased the risk of death compared with a less-intensive standard treatment strategy. Study participants receiving intensive blood glucose lowering treatment will now receive the less-intensive standard treatment.

The ACCORD (Action to Control Cardiovascular Risk in Diabetes) study enrolled 10,251 participants. Of these, 257 in the intensive treatment group have died, compared with 203 within the standard treatment group. This is a difference of 54 deaths, or 3 per 1,000 participants each year, over an average of almost four years of treatment. The death rates in both groups were lower than seen in similar populations in other studies.

"A thorough review of the data shows that the medical treatment strategy of intensively reducing blood sugar below current clinical guidelines causes harm in these especially high-risk patients with type 2 diabetes," said Elizabeth G. Nabel, M.D., director, NHLBI. "Though we have stopped this part of the trial, we will continue to care for these participants, who now will receive the less-intensive standard treatment. In addition, we will continue to monitor the health of all participants, seek the underlying causes for this finding, and carry on with other important research within ACCORD."

In stopping this part of the trial, Nabel accepted the recommendation of the 10-member Data and Safety Monitoring Board (DSMB) – an independent advisory group of experts in diabetes, cardiovascular disease, epidemiology, patient care, biostatistics, medical ethics, and clinical trial design that has been monitoring ACCORD since it began.


(Editor compiled and published Intensive blood glucose lowering treatment proved fatal for diabetes patients at HealthNewsTrack on February 7, 2008 sourced from National Heart, Lung, and Blood Institute - http://www.nhlbi.nih.gov/)

Diabetes - recent articles and current news stories:

- Bariatric surgery better for obese with type 2 diabetes
- Less sleep means higher risk of diabetes and obesity
- Bariatric surgery improves and reverses diabetes
- Gestational diabetes and poverty increased ADHD risk in offspring
- Low calorie diet improves heart function in diabetic obese patients

Most related articles:

- Intensive blood glucose lowering treatment proved fatal for diabetes patients
- Part of ACCORD study halted due to safety concerns - 10.4
- Low blood sugar not good for kidney disease patients - 7.8
- Intensive statin therapy increases risk of diabetes - 6.7
- Glucose challenge test for diabetes screening - 6.7

More related articles:

- Blood glucose, Diabetes, Cardiovascular disease, Type 2 diabetes, Heart attack, Stroke
- Part of ACCORD study halted due to safety concerns - 15
- Avandia use is restricted for diabetes patients - 12.3
- Youth with type 1 diabetes linked to insulin resistance - 11.2
- Safely reduce BP in patients with diabetes and heart disease - 10.9

Diabetes related articles:

- New diabetes risk assessment developed - 3.1
- One person diagnosed with diabetes every three minutes - 3
- Nicole Johnson takes action for type 1 diabetes research - 2.8
- Lilly donated Insulin to International Diabetes Federation's Life for a Child Program - 2.8
- Victoza, liraglutide approved for type 2 diabetes - 2.8

Diabetes article/news source:

Read more health articles from National Heart, Lung, and Blood Institute and health articles from USA.

Diabetes - search related terms:

Blood glucose, Cardiovascular disease, Diabetes, Heart attack, Stroke, Type 2 diabetes,
Diabetes books,

Searched keywords: diabetes (11), diabetes patients (10),
Mission
Health Newstrack is dedicated to serve recent and updated health & medical research, events/news, views/reviews to its subscribers and free access to general public, health & medical professionals, and other health seekers worldwide online with a user-friendly system.

Current news
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, USA has stopped one treatment within a large, ongoing North American clinical trial of diabetes and cardiovascular disease 18 months early due to safety concerns after review of available data, although the study will continue.

Diabetes
What is Diabetes?
About Diabetes -- Diabetes mellitus is a condition in which the pancreas no longer produces enough insulin or when cells stop responding to the insulin that is produced, so that glucose in the blood cannot be absorbed into the cells of the body. Symptoms include frequent urination, lethargy, excessive thirst, and hunger. The treatment includes changes in diet, oral medications, and in some cases, daily injections of insulin.


List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
4.79